New real-time-PCR method to identify single point mutations in hepatitis C virus

Area of Science:

• Virology
• Molecular Diagnostics
• Genetics

Background:

• Hepatitis C virus (HCV) harbors highly variable genomes.
• Single point mutations, like Q80K in the NS3 protease gene, confer resistance to direct-acting antiviral agents.
• Existing diagnostic methods struggle with high-throughput detection of mutations in variable genomes like HCV.

Purpose of the Study:

• To develop a rapid and cost-effective diagnostic strategy for identifying single point mutations in variable viral genomes.
• To enable early detection of treatment-resistant mutations in Hepatitis C Virus (HCV) infections.

Main Methods:

• Developed a novel real-time PCR method with sequence-specific probe hybridization.
• Implemented a nucleotide homogenization technique to improve detection accuracy in variable regions.
• Utilized fluorescence resonance energy transfer (FRET) probe melting curve analysis.

Main Results:

• The new method successfully identified Q80K substitutions in HCV G1 serum samples with 10% sensitivity.
• Performance was comparable to Sanger sequencing, the current gold standard.
• Validated in a population of 202 HCV G1-infected individuals, detecting Q80K in 14.6% of G1a subtypes.

Conclusions:

• A fast, low-cost diagnostic strategy for single point mutations in HCV has been successfully developed.
• The technique, based on real-time PCR and FRET, is adaptable for detecting various mutations in variable genomes.
• This diagnostic approach can aid in personalized treatment strategies for HCV patients.